Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 11, 2023

Total Value ($000): $316 (100.0% shares, 0.0% debt)

Holdings (12)

BIIB BIOGEN INC 16.0%
Value ($000) $50 Shares 176,826 Est. Cost $267.94 Unrealized +11.2%
UTHR UNITED THERAPEUTICS CORP 14.2%
Value ($000) $45 Shares 202,715 Est. Cost $127.97 Unrealized +73.1%
REGN REGENERON PHARMACEUTICALS 13.5%
Value ($000) $43 Shares 59,188 Est. Cost $342.96 Unrealized +123.6%
EXEL EXELIXIS INC 12.9%
Value ($000) $41 Shares 2,133,703 Est. Cost $18.49 Unrealized +4.3%
ALKS ALKERMES PLC 10.9%
Value ($000) $35 Shares 1,103,451 Est. Cost $18.73 Unrealized +61.6%
CAH CARDINAL HEALTH INC 10.6%
Value ($000) $33 Shares 353,714 Est. Cost $56.53 Unrealized +42.6%
— TARO PHARMACEUTICAL INDUS 7.7%
Value ($000) $24 Shares 643,080 Est. Cost $67.97 Unrealized —
EMBC EMBECTA CORP 7.3%
Value ($000) $23 Shares 1,070,810 Est. Cost $25.42 Unrealized -3.7%
ENTA ENANTA PHARMACEUTICALS INC 4.7%
Value ($000) $15 Shares 687,613 Est. Cost $43.86 Unrealized -32.8%
VNDA VANDA PHARMACEUTICALS INC 0.8%
Value ($000) $2 Shares 362,951 Est. Cost $10.33 Unrealized -37.9%
KOD KODIAK SCIENCES INC 0.8%
Value ($000) $2 Shares 344,634 Est. Cost $33.04 Unrealized -81.5%
EGRX EAGLE PHARMACEUTICALS INC 0.7%
Value ($000) $2 Shares 113,437 Est. Cost $44.36 Unrealized -46.5%